OraSure Technologies, Inc. (NASDAQ:OSUR)

CAPS Rating: 2 out of 5

The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.

Results 41 - 44 of 44 : « Previous 1 2 3

Recs

0
Member Avatar bugolfer (97.15) Submitted: 9/27/2006 5:45:49 PM : Outperform Start Price: $8.28 OSUR Score: +20.34

Will the HIV test become the standard like the pap test? If it does this company will stand to benefit. The CDC wants all people tested for HIV when they visit the doctor. Orasure is also working on a home test for HIV which could be approved in the next few years. Decent financials but not stellar. Should see some improvement over the next two years.

Recs

0
Member Avatar Redhottrader (28.42) Submitted: 9/27/2006 4:22:26 AM : Outperform Start Price: $8.02 OSUR Score: +24.21

HIV tests will skyrocket.

Recs

2
Member Avatar caccitore (51.46) Submitted: 9/23/2006 8:16:12 PM : Outperform Start Price: $8.20 OSUR Score: +20.03

fdc

Recs

2
Member Avatar Drakeusx (43.80) Submitted: 9/21/2006 5:40:57 PM : Underperform Start Price: $8.55 OSUR Score: -15.39

Too much of a large jump on nothing news.

Results 41 - 44 of 44 : « Previous 1 2 3

Featured Broker Partners


Advertisement